Form D · Pharmaceuticals
ENDOGENX INC
Los Gatos, CA · CIK 0001438969
Offering snapshot reported Jun 19, 2009 · SEC filing
- Reported sold
- $1.36M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2009 | Initial | $1,361,300 | No comparison | 1 | SEC filing |
| Jan 21, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $43.5K
- Form D file number
- 021-119769
Source: Form D, filed Jun 19, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Dunn | Director, Executive |
| Anil Gulati | Director, Executive |
| Dennis Rowland | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
15595 Los Gatos Bvd
Los Gatos, CA, 95032
Los Gatos, CA, 95032